Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -92,632 | -63,465 | -37,914 | -101,744 | -70,981 |
| Depreciation Amortization | -1,882 | -1,318 | -746 | -979 | 768 |
| Accounts receivable | N/A | N/A | N/A | 2,000 | 2,000 |
| Accounts payable and accrued liabilities | 1,323 | -1,724 | 1,042 | -1,705 | -1,617 |
| Other Working Capital | -24,599 | -12,821 | -6,831 | -37,966 | -37,216 |
| Other Operating Activity | 22,936 | 17,864 | 6,592 | 22,412 | 16,531 |
| Operating Cash Flow | $-94,854 | $-61,464 | $-37,857 | $-117,982 | $-90,515 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -630 | -515 | -195 | -1,526 | -1,300 |
| Purchase Of Investment | -208,339 | -168,874 | -120,263 | -310,574 | -259,549 |
| Sale Of Investment | 243,035 | 170,885 | 109,255 | 353,526 | 268,423 |
| Investing Cash Flow | $34,066 | $1,496 | $-11,203 | $41,426 | $7,574 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 46,695 | 44,293 | 42,982 | 81,958 | 80,939 |
| Other Financing Activity | 0 | 0 | 0 | 448 | 0 |
| Financing Cash Flow | $46,695 | $44,293 | $42,982 | $82,406 | $80,939 |
| Beginning Cash Position | 69,808 | 69,808 | 69,808 | 63,958 | 63,958 |
| End Cash Position | 55,715 | 54,133 | 63,730 | 69,808 | 61,956 |
| Net Cash Flow | $-14,093 | $-15,675 | $-6,078 | $5,850 | $-2,002 |
| Free Cash Flow | |||||
| Operating Cash Flow | -94,854 | -61,464 | -37,857 | -117,982 | -90,515 |
| Capital Expenditure | -630 | -515 | -195 | -1,526 | -1,300 |
| Free Cash Flow | -95,484 | -61,979 | -38,052 | -119,508 | -91,815 |